Therapeutic Formulations from a Trusted Source

At ZYUS, we place the upmost importance on ensuring our therapeutic formulations are high-quality and consistent for the patients we serve. Our formulations undergo rigorous testing from production and packaging to distributions, to ensure we produce standardized therapeutic formulations.

We adhere to national and international standards for pharmaceutical production and distribution of products. Our facility will be inspected by regulators to verify compliance to Good Manufacturing Practices (GMP). The GMP principles apply to the production process, the cleaning of equipment and facilities, raw materials, packaging and distribution. Our robust quality management system focuses on operational excellence that will not only meet regulatory expectations, but exceed them. We strive to conduct business in compliance with all applicable laws, regulations, codes, and standards.

Cannabinoids Rooted in Quality

We are devoted to sourcing dried cannabis as raw material exclusively from vetted cannabis producers licensed and regulated by Health Canada. As a part of the vetting process, ZYUS maintains standards that not only meet, but exceed Health Canada’s Good Production Practices (GPP).

State-of-the-Art Extraction Technology

We refine our cannabinoid extracts in an industry leading, pharmaceutical-grade ethanol extraction facility to enable production on a global scale. Ethanol extraction allows for cannabinoids to be extracted from raw material using food grade alcohol.  This method provides higher extraction efficiency compared to other extraction methods while ensuring the highest product quality and shelf life. After the extraction process, the alcohol and any excess water is removed by evaporation resulting in a concentrated resin. This resin is heated to activate the therapeutic benefit of the cannabinoids. Pharmaceutical grade olive oil is used as a carrier oil because of its low allergenic indices, antioxidant benefits, anti-microbial properties and subtle taste.